Skip to Main Content

Paper Details

11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration.
JCI Insight
13
2021
11-Ketotestosterone, 11-ketotestosterone, 11KT, AR, AR-regulated genes, CRPC, Metastatic tumor, RNA, androgen, androgen receptor, androgens, castration-resistant prostate cancer, patients, plasma, prostate cancer, steroid, testosterone
Author NameAffiliation
Lisanne F van DesselErasmus MC Cancer Institute
Job van RietErasmus MC Cancer Institute
Paul Hamberg
Ronald de WitErasmus MC Cancer Institute
Wiebke ArltInstitute of Metabolism and Systems Research, University of Birmingham
Martijn P LolkemaErasmus MC Cancer Institute
  • 1 - 6

Datasets

Release 1.2